![]() |
|
|
Vol. 280, Issue 2, 551-560, 1997
Department of Biopharmacy, School of Pharmaceutical Sciences,
University of Shizuoka, Shizuoka, Japan
This study was performed to evaluate quantitatively the brain
distribution and the efflux transport across the blood-brain barrier of
probenecid, using in vivo microdialysis and in
situ brain perfusion techniques. The brain interstitial fluid
(ISF)-to-plasma cerebrospinal fluid (CSF)-to-plasma and brain
tissue-to-plasma unbound concentration ratios of probenecid at steady
state were less than unity, which suggests restricted distribution in
the brain. An uphill concentration gradient from ISF to plasma and a
downhill concentration gradient from CSF to ISF were observed. Kinetic
analysis revealed that the efflux clearance from brain ISF to plasma
(0.0373 ml/min/g brain) was significantly greater than the influx
clearance from plasma to brain (0.00733 ml/min/g brain). The ratio of
the ISF concentration (Cisf) to the plasma unbound
concentration (Cp,f) of probenecid was increased 2- to 3-fold by salicylate (3.7 mM) and benzoate (3.6 mM), which are accepted
as substrates of the monocarboxylic acid transport system, compared
with the same ratio for the control. In addition, the ratio
Cisf/Cp,f was increased by treatment with
N-ethylmaleimide, a sulfhydryl-modifying agent, whereas
p-aminohippuric acid and choline did not produce increasing
effects on Cisf/Cp,f. These data suggest that
the restricted distribution of probenecid in the brain may be ascribed
to efficient efflux from the brain ISF, which may be regulated by the
monocarboxylic acid transport system at a relatively high ISF
concentration.
This article has been cited by other articles:
![]() |
I. Bhattacharya and K. M. K. Boje GHB ({gamma}-Hydroxybutyrate) Carrier-Mediated Transport across the Blood-Brain Barrier J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 92 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yan and E. M. Taylor Neotrofin Is Transported Out of Brain by a Saturable Mechanism: Possible Involvement of Multidrug Resistance and Monocarboxylic Acid Transporters Drug Metab. Dispos., May 1, 2002; 30(5): 513 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tamai, J. Yamashita, Y. Kido, A. Ohnari, Y. Sai, Y. Shima, K. Naruhashi, S. Koizumi, and A. Tsuji Limited Distribution of New Quinolone Antibacterial Agents into Brain Caused by Multiple Efflux Transporters at the Blood-Brain Barrier J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 146 - 152. [Abstract] [Full Text] |
||||
![]() |
T. Kitazawa, T. Terasaki, H. Suzuki, A. Kakee, and Y. Sugiyama Efflux of Taurocholic Acid Across the Blood-Brain Barrier: Interaction with Cyclic Peptides J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 890 - 895. [Abstract] [Full Text] |
||||